+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibodies"

Antibody Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Antibody Collaboration and Licensing Deals 2016-2023

  • Report
  • November 2023
  • 950 Pages
  • Global
From
From
From
From
From
Monoclonal Antibody Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Monoclonal Antibody Collaboration and Licensing Deals 2016-2023

  • Report
  • November 2023
  • 500 Pages
  • Global
From
From
Global Biopharmaceuticals Market Outlook to 2027 - Product Thumbnail Image

Global Biopharmaceuticals Market Outlook to 2027

  • Report
  • July 2023
  • 80 Pages
  • Global
From
From
Loading Indicator

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments. The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more